What is Virtual Incision?
Headquartered in Lincoln, Nebraska, Virtual Incision is at the forefront of the surgical robotics revolution. The company specializes in developing miniaturized, high-performance robotic platforms designed to provide surgeons with unprecedented mobility and flexibility. By focusing on minimally invasive procedures, Virtual Incision aims to democratize access to advanced surgical care, making complex operations more accessible and efficient for healthcare providers globally. Their core technology is engineered to reduce the physical footprint of robotic surgery, thereby lowering barriers to adoption for hospitals and surgical centers that require versatile, space-efficient solutions.
How much funding has Virtual Incision raised?
Virtual Incision has raised a total of $114.9M across 7 funding rounds:
Private Equity
$1.8M
Series A
$3.9M
Private Equity
$1.8M
Private Equity
$11.2M
Series B
$20M
Debt
$150K
Series C
$76M
Private Equity (2010): $1.8M with participation from Bluestem Capital and PrairieGold Venture Partners
Series A (2010): $3.9M led by Bluestem Capital and PrairieGold Venture Partners
Private Equity (2015): $1.8M supported by Bluestem Capital and PrairieGold Venture Partners
Private Equity (2015): $11.2M featuring Bluestem Capital and PrairieGold Venture Partners
Series B (2020): $20M backed by PrairieGold Venture Partners, Genesis Innovation Group, and Bluestem Capital
Debt (2020): $150K with participation from PPP
Series C (2023): $76M led by Bluestem Capital, Baird Capital, and Endeavour Vision
Key Investors in Virtual Incision
Bluestem Capital
Bluestem Capital is a venture capital firm based in Sioux Falls, South Dakota, focusing on private equity investments in the Midwest to support and grow companies within its portfolio.
Baird Capital
Baird Capital is a private equity and venture capital firm that invests in founder-led B2B tech and services companies globally, providing operational support to foster growth.
Endeavour Vision
Endeavour Vision is a leading investment advisory firm specializing in transformative healthcare technologies, particularly in medical devices and digital health.
What's next for Virtual Incision?
With the successful closure of its latest funding round, Virtual Incision is poised to scale its manufacturing capabilities and accelerate clinical adoption. The strategic focus will likely shift toward navigating regulatory pathways for new product iterations and expanding its footprint in the global medical device market. As the company matures, the integration of its proprietary technology into standard surgical workflows will be critical for long-term market penetration. Investors are closely monitoring the firm's ability to maintain its competitive edge in the rapidly evolving landscape of digital health and robotic-assisted surgery, where precision and patient-centric design remain the primary drivers of value creation.
See full Virtual Incision company page
